Companion animal vaccine market to reach $5.38 billion by 2030

By AI, Created 11:15 AM UTC, May 20, 2026, /AGP/ – The companion animal veterinary vaccines market is projected to grow from $3.94 billion in 2025 to $4.19 billion in 2026, according to The Business Research Company. The report points to rising pet ownership, higher spending on pet health and new vaccine formats as key drivers, with North America leading the market in 2025.

Why it matters: - The companion animal veterinary vaccines market is expanding as pet owners spend more on preventive care and disease protection. - The market is projected to reach $5.38 billion by 2030, signaling sustained demand for vaccines for dogs, cats and other companion animals. - Growth in vaccine use can reduce later treatment costs and support broader animal health outcomes.

What happened: - The Business Research Company published a market report on companion animal veterinary vaccines on May 5, 2026. - The report estimates the market will rise from $3.94 billion in 2025 to $4.19 billion in 2026, a 6.4% CAGR. - The report forecasts the market will reach $5.38 billion by 2030, at a 6.5% CAGR. - North America was the largest regional market in 2025. - Asia-Pacific ranked second in 2025.

The details: - Companion animal vaccines are designed to stimulate immune defenses and protect pets, including dogs, cats and birds, from disease. - Historical growth has been supported by a larger companion animal population, more infectious diseases in pets, more veterinary facilities, greater awareness of vaccination benefits and better cold chain logistics. - The report says future growth will be driven by pet humanization, higher pet healthcare spending, vaccine innovation, urban pet ownership growth and supportive government policies. - The report expects wider adoption of combination vaccines, stronger preventive care, broader vaccination coverage, more recombinant and DNA-based vaccines, and more oral and minimally invasive delivery methods. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report offers a free sample and the full market report.

Between the lines: - Higher pet spending is reinforcing demand for preventive products, not just treatment after illness. - The move toward combination, recombinant and DNA-based vaccines suggests the market is shifting toward more advanced and easier-to-administer products. - North America’s lead points to mature veterinary infrastructure, while Asia-Pacific’s No. 2 position reflects growing pet adoption and awareness. - A separate February 2025 report cited American pet owners spending about $13.42 billion on pet services, up 8.5% from $12.36 billion in 2022.

What’s next: - The report expects continued market expansion through 2030 as pet ownership rises and vaccine technology improves. - Demand should increase for preventive care products that are less invasive and easier to administer. - More adoption of combination vaccines could reshape product development and distribution across veterinary channels. - The Business Research Company also highlighted related reports on veterinary vaccines, dog vaccines and veterinary antibiotics.

The bottom line: - Companion animal vaccines are moving from a steady-growth niche into a larger preventive care market powered by pet spending, innovation and broader global adoption.